A comparative study of smart spectrophotometric methods for simultaneous determination of sitagliptin phosphate and metformin hydrochloride in their binary mixture
- 1 October 2015
- journal article
- research article
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 149, 441-451
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Stability-Indicating RP-HPLC Method for Simultaneous Determination of Metformin Hydrochloride and Sitagliptin Phosphate in Dosage FormsChromatographia, 2013
- Simultaneous Determination of Sitagliptin Phosphate Monohydrate and Metformin Hydrochloride in Tablets by a Validated UPLC MethodScientia Pharmaceutica, 2012
- Liquid chromatographic determination of sitagliptin either alone or in ternary mixture with metformin and sitagliptin degradation productTalanta, 2011
- Simultaneous quantitation of metformin and sitagliptin from mouse and human dried blood spots using laser diode thermal desorption tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2011
- Determination of sitagliptinin human plasma using protein precipitation and tandem mass spectrometryJournal of Chromatography B, 2010
- Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat dietClinical Science, 2010
- LC–MS–MS Development and Validation for Simultaneous Quantitation of Metformin, Glimepiride and Pioglitazone in Human Plasma and Its Application to a Bioequivalence StudyChromatographia, 2009
- Determination of sitagliptin in human urine and hemodialysate using turbulent flow online extraction and tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2008
- Sensitive liquid chromatography tandem mass spectrometry method for the quantification of sitagliptin, a DPP‐4 inhibitor, in human plasma using liquid–liquid extractionBiomedical Chromatography, 2007
- Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin as Monotherapy on Glycemic Control in Patients With Type 2 DiabetesDiabetes Care, 2006